Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effect of Regular Kefir Consumption on Metabolic Syndrome Parameters, Inflammatory Response, and Gut Microbiota: A Parallel-Group, Randomized, Controlled Clinical Study

NCT03966846 is registered in ClinicalTrials.gov with Izmir Katip Celebi University as lead sponsor.

NCT NCT03966846
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03966846 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effect of Regular Kefir Consumption on Metabolic Syndrome Parameters, Inflammatory Response, and Gut Microbiota: A Parallel-Group, Randomized, Controlled Clinical Study
Lead sponsor
Izmir Katip Celebi University
Phase
Not applicable
Overall status
Completed
Start date
March 31, 2015
Completion date
July 31, 2017
Enrollment
62 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

hyperlipidemias, hypertension, insulin resistance, metabolic syndrome, obesity